125 related articles for article (PubMed ID: 8612654)
21. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders.
Gupta NK; Bomanji JB; Waddington W; Lui D; Costa DC; Verbruggen AM; Ell PJ
Eur J Nucl Med; 1995 Jul; 22(7):617-24. PubMed ID: 7498222
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
25. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
[TBL] [Abstract][Full Text] [Related]
26. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of technetium-99m ethylenedicysteine clearance.
Kabasakal L; Halaç M; Alkan E; Ozçelik N; Uslu I
Eur J Nucl Med; 1999 Aug; 26(8):900-2. PubMed ID: 10436204
[TBL] [Abstract][Full Text] [Related]
28. Modification of measurement of effective renal plasma flow from blood pool clearance curve of I-123-orthoiodohippurate using single blood sampling.
Akutsu T; Komatani A; Yamaguchi K; Takahashi K; Konta T
Radiat Med; 1998; 16(4):245-50. PubMed ID: 9814418
[TBL] [Abstract][Full Text] [Related]
29. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent.
Van Nerom CG; Bormans GM; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1993 Sep; 20(9):738-46. PubMed ID: 8223766
[TBL] [Abstract][Full Text] [Related]
30. Prediction of renal transplant survival from early postoperative radioisotope studies.
Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of gamma camera-based measurement of individual kidney function using iodine-123 orthoiodohippurate.
Oriuchi N; Inoue T; Hayashi I; Mizuiri S; Kosaka N; Nishikawa J; Sasaki Y; Endo K
Eur J Nucl Med; 1996 Apr; 23(4):371-5. PubMed ID: 8612655
[TBL] [Abstract][Full Text] [Related]
32. 99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease.
Taylor AT; Lipowska M; Cai H
J Nucl Med; 2013 Apr; 54(4):578-84. PubMed ID: 23424193
[TBL] [Abstract][Full Text] [Related]
33. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
34. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
[TBL] [Abstract][Full Text] [Related]
35. Measurement of effective renal plasma flow (ERPF) with 123I-orthoiodohippurate (I-123-OIH).
Nakashima R; Tomiguchi S; Kojima A; Takaki Y; Tsuji A; Takahashi M
Radiat Med; 1996; 14(3):147-50. PubMed ID: 8827809
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
Kengen RA; Meijer S; Beekhuis H; Piers DA
J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
[TBL] [Abstract][Full Text] [Related]
37. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
Shirakawa S; Tamaki N; Torizuka T; Fujita T; Yano S; Tsuchimochi S; Yonekura Y; Konishi J; Terai A
Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
[TBL] [Abstract][Full Text] [Related]
38. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetics of 99mTc-MAG3 and 131I-OIH: comparative study based on 2 compartment model analysis].
Shuke N; Takashio T; Sato J; Ishikawa Y; Saito Y; Yamamoto W; Aburano T; Mizunaga M; Kaneko S; Yachiku S; Ogawa Y; Kikuchi K; Sasajima T; Kubo Y
Kaku Igaku; 1996 May; 33(5):513-20. PubMed ID: 8699619
[TBL] [Abstract][Full Text] [Related]
40. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
Bagni B; Bagni I; Orsolon P; Corazzari T
J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
